111 Capital Makes New Investment in Tenet Healthcare Corporation $THC

111 Capital bought a new stake in Tenet Healthcare Corporation (NYSE:THC) in the 2nd quarter, Holdings Channel reports. The institutional investor bought 1,387 shares of the company’s stock, valued at approximately $244,000.

Other large investors have also made changes to their positions in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in Tenet Healthcare during the first quarter valued at approximately $26,000. Wayfinding Financial LLC bought a new position in shares of Tenet Healthcare in the 1st quarter valued at $28,000. SVB Wealth LLC bought a new stake in shares of Tenet Healthcare during the 1st quarter worth $30,000. N.E.W. Advisory Services LLC acquired a new stake in Tenet Healthcare in the first quarter valued at about $31,000. Finally, Brooklyn Investment Group raised its stake in Tenet Healthcare by 908.7% during the first quarter. Brooklyn Investment Group now owns 232 shares of the company’s stock worth $31,000 after acquiring an additional 209 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Lisa Y. Foo sold 8,000 shares of the business’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $179.53, for a total transaction of $1,436,240.00. Following the transaction, the executive vice president owned 20,878 shares in the company, valued at $3,748,227.34. The trade was a 27.70% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Christopher S. Lynch sold 3,952 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $176.39, for a total transaction of $697,093.28. Following the completion of the sale, the director owned 12,358 shares of the company’s stock, valued at $2,179,827.62. The trade was a 24.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 90,722 shares of company stock worth $17,161,015. 0.81% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Guggenheim raised their price target on shares of Tenet Healthcare from $180.00 to $188.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Wolfe Research lowered shares of Tenet Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Barclays increased their price target on Tenet Healthcare from $208.00 to $229.00 and gave the company an “overweight” rating in a research note on Thursday, September 18th. Truist Financial boosted their price objective on Tenet Healthcare from $190.00 to $205.00 and gave the stock a “buy” rating in a research report on Wednesday, July 16th. Finally, Bank of America lifted their price target on Tenet Healthcare from $205.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $196.81.

Tenet Healthcare Trading Down 1.5%

NYSE:THC opened at $199.86 on Tuesday. Tenet Healthcare Corporation has a 52 week low of $109.82 and a 52 week high of $205.99. The firm’s fifty day moving average is $182.72 and its 200-day moving average is $163.26. The firm has a market cap of $17.66 billion, a P/E ratio of 12.80, a P/E/G ratio of 0.87 and a beta of 1.52. The company has a debt-to-equity ratio of 2.39, a quick ratio of 1.63 and a current ratio of 1.71.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 EPS for the quarter, beating analysts’ consensus estimates of $2.84 by $1.18. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The business had revenue of $5.27 billion for the quarter, compared to analysts’ expectations of $5.16 billion. During the same quarter in the prior year, the firm posted $2.31 earnings per share. The business’s quarterly revenue was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. Equities analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.